Statistics

Total Visits

Views
Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)33

Select a period of time:

Number of views in the range

Views
Erlotinib as second-line treatment for patients with advanced non-small-cell lung cancer and non-squamous histology: a galician lung cancer group study (ggcp041/09)19

Views

Views
November 20240
December 20240
January 20251
February 20251
March 202515
April 20252
May 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
United States2
Spain1
United Kingdom1
 

Top cities views

Views
Council Bluffs1